Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors
Clinical trial NCT05537987 · UNKNOWN
Trial details
- NCT number
- NCT05537987
- Sponsor
- InnoCare Pharma Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2023-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.